Gennaro Palmiotti

653 total citations
22 papers, 332 citations indexed

About

Gennaro Palmiotti is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Gennaro Palmiotti has authored 22 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Surgery. Recurrent topics in Gennaro Palmiotti's work include Cancer Immunotherapy and Biomarkers (10 papers), Radiomics and Machine Learning in Medical Imaging (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Gennaro Palmiotti is often cited by papers focused on Cancer Immunotherapy and Biomarkers (10 papers), Radiomics and Machine Learning in Medical Imaging (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Gennaro Palmiotti collaborates with scholars based in Italy and Spain. Gennaro Palmiotti's co-authors include Alessandro Rizzo, Antonio Cusmai, Gennaro Gadaleta‐Caldarola, L. Rinaldi, Silvana Acquafredda, A. Misino, Elisabetta Montagna, Francesco Giotta, Maria Colomba Comes and Raffaella Massafra and has published in prestigious journals such as Oncotarget, Cells and Cancers.

In The Last Decade

Gennaro Palmiotti

22 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gennaro Palmiotti Italy	9	163	105	74	61	55	22	332
Franz J. Hilke Germany	10	114 0.7×	68 0.6×	62 0.8×	89 1.5×	31 0.6×	15	276
Davide Bosso Italy	12	132 0.8×	167 1.6×	133 1.8×	70 1.1×	57 1.0×	18	366
Nikoletta Sidiropoulos United States	8	163 1.0×	114 1.1×	76 1.0×	135 2.2×	29 0.5×	21	336
Dayang Hui China	8	116 0.7×	67 0.6×	51 0.7×	45 0.7×	43 0.8×	13	285
Francesca Comito Italy	10	131 0.8×	113 1.1×	77 1.0×	79 1.3×	29 0.5×	26	331
Zuoxing Niu China	9	152 0.9×	103 1.0×	163 2.2×	112 1.8×	55 1.0×	40	376
Lihou Dong China	9	163 1.0×	56 0.5×	86 1.2×	34 0.6×	61 1.1×	19	294
Alexander B. Sibley United States	12	171 1.0×	80 0.8×	124 1.7×	71 1.2×	23 0.4×	27	393
Francesca Sparano Italy	9	219 1.3×	103 1.0×	113 1.5×	65 1.1×	21 0.4×	19	369
Long-Zi Liu China	8	109 0.7×	74 0.7×	96 1.3×	81 1.3×	108 2.0×	8	325

Countries citing papers authored by Gennaro Palmiotti

Since Specialization

Citations

This map shows the geographic impact of Gennaro Palmiotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gennaro Palmiotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gennaro Palmiotti more than expected).

Fields of papers citing papers by Gennaro Palmiotti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gennaro Palmiotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gennaro Palmiotti. The network helps show where Gennaro Palmiotti may publish in the future.

Co-authorship network of co-authors of Gennaro Palmiotti

This figure shows the co-authorship network connecting the top 25 collaborators of Gennaro Palmiotti. A scholar is included among the top collaborators of Gennaro Palmiotti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gennaro Palmiotti. Gennaro Palmiotti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Comes, Maria Colomba, Annarita Fanizzi, Samantha Bove, et al.. (2024). Explainable 3D CNN based on baseline breast DCE-MRI to give an early prediction of pathological complete response to neoadjuvant chemotherapy. Computers in Biology and Medicine. 172. 108132–108132. 8 indexed citations

Fanizzi, Annarita, Agnese Latorre, Samantha Bove, et al.. (2023). Prognostic power assessment of clinical parameters to predict neoadjuvant response therapy in HER2‐positive breast cancer patients: A machine learning approach. Cancer Medicine. 12(22). 20663–20669. 3 indexed citations

Rizzo, Alessandro, Gennaro Palmiotti, Veronica Mollica, et al.. (2023). Hypertransaminasemia in Metastatic Renal Cell Carcinoma Patients Receiving Immune-Based Combinations: A Meta-Analysis. Immunotherapy. 15(2). 117–126. 1 indexed citations

Rizzo, Alessandro, Angela Dalia Ricci, Antonio Cusmai, et al.. (2022). Systemic Treatment for Metastatic Biliary Tract Cancer: State of the Art and a Glimpse to the Future. Current Oncology. 29(2). 551–564. 5 indexed citations

Rizzo, Alessandro, Antonio Cusmai, Gennaro Gadaleta‐Caldarola, & Gennaro Palmiotti. (2022). Which role for predictors of response to immune checkpoint inhibitors in hepatocellular carcinoma?. Expert Review of Gastroenterology & Hepatology. 16(4). 333–339. 72 indexed citations

Massafra, Raffaella, Samantha Bove, Daniele La Forgia, et al.. (2022). An Invasive Disease Event-Free Survival Analysis to Investigate Ki67 Role with Respect to Breast Cancer Patients’ Age: A Retrospective Cohort Study. Cancers. 14(9). 2215–2215. 6 indexed citations

Rizzo, Alessandro, Veronica Mollica, Matteo Santoni, Gennaro Palmiotti, & Francesco Massari. (2022). Pathologic Complete Response in Urothelial Carcinoma Patients Receiving Neoadjuvant Immune Checkpoint Inhibitors: A Meta-Analysis. Journal of Clinical Medicine. 11(4). 1038–1038. 1 indexed citations

Ricci, Angela Dalia, Alessandro Rizzo, Gennaro Palmiotti, & Giovanni Brandi. (2022). PD-L1 assessment in breast cancer immunotherapy: a critical overview. Expert Review of Precision Medicine and Drug Development. 7(1). 58–59. 3 indexed citations

Gadaleta‐Caldarola, Gennaro, Alessandro Rizzo, Vincenzo Dadduzio, et al.. (2022). Pemigatinib in Intrahepatic Cholangiocarcinoma: A Work in Progress. Current Oncology. 29(10). 7925–7931. 3 indexed citations

10.

Rizzo, Alessandro, Antonio Cusmai, Silvana Acquafredda, et al.. (2022). Fluoropyrimidine-based doublet chemotherapy as second-line treatment for advanced biliary tract cancer: a meta-analysis of ABC-06 and NIFTY. Expert Review of Gastroenterology & Hepatology. 16(3). 273–278. 3 indexed citations

11.

Rizzo, Alessandro, Riccardo Carloni, Angela Dalia Ricci, et al.. (2022). Treatment-related adverse events of first-line immunotherapy versus sorafenib for advanced hepatocellular carcinoma: a meta-analysis. Expert Opinion on Drug Safety. 22(4). 323–329. 5 indexed citations

12.

Rizzo, Alessandro, Antonio Cusmai, Silvana Acquafredda, et al.. (2022). KEYNOTE-522, IMpassion031 and GeparNUEVO: changing the paradigm of neoadjuvant immune checkpoint inhibitors in early triple-negative breast cancer. Future Oncology. 18(18). 2301–2309. 52 indexed citations

13.

Carloni, Riccardo, Alessandro Rizzo, Antonio Cusmai, et al.. (2022). Advances in Novel Systemic Therapies for Advanced Hepatocellular Carcinoma. Future Medicinal Chemistry. 14(20). 1455–1470. 2 indexed citations

14.

Rizzo, Alessandro, Raffaella Massafra, Annarita Fanizzi, et al.. (2022). Adenosine pathway inhibitors: novel investigational agents for the treatment of metastatic breast cancer. Expert Opinion on Investigational Drugs. 31(7). 707–713. 3 indexed citations

15.

Rizzo, Alessandro, Antonio Cusmai, Silvana Acquafredda, et al.. (2022). Impact of Proton Pump Inhibitors and Histamine-2-Receptor Antagonists on Non-Small Cell Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis. Cancers. 14(6). 1404–1404. 82 indexed citations

16.

Rizzo, Alessandro, Antonio Cusmai, Gennaro Gadaleta‐Caldarola, & Gennaro Palmiotti. (2022). Current and Future Role of Neoadjuvant Chemoimmunotherapy for Early Triple-Negative Breast Cancer: Which Way to Go Forward. Medicina. 58(5). 600–600. 3 indexed citations

17.

Rizzo, Alessandro, Matteo Santoni, Veronica Mollica, et al.. (2022). The Impact of Concomitant Proton Pump Inhibitors on Immunotherapy Efficacy among Patients with Urothelial Carcinoma: A Meta-Analysis. Journal of Personalized Medicine. 12(5). 842–842. 10 indexed citations

18.

Forgia, Daniele La, Maria Colomba Comes, Francesco Giotta, et al.. (2021). Response Predictivity to Neoadjuvant Therapies in Breast Cancer: A Qualitative Analysis of Background Parenchymal Enhancement in DCE-MRI. Journal of Personalized Medicine. 11(4). 256–256. 22 indexed citations

19.

Moscarella, Elvira, Riccardo Pampena, Gennaro Palmiotti, et al.. (2019). A meta‐analysis on the influence of partial biopsy of primary melanoma on disease recurrence and patient survival. Journal of the European Academy of Dermatology and Venereology. 34(2). 279–284. 6 indexed citations

20.

Rubini, Giuseppe, et al.. (2011). Whole-body MR-DWIBS vs. [18F]-FDG-PET/CT in the study of malignant tumors: a retrospective study. La radiologia medica. 117(2). 293–311. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact